Testaforte 50 mg in 1 ml or 100 mg in 2 ml Cream.
PDF Leaflet Revision Date: 30 May 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Testosterone replacement therapy for male hypogonadism.
Dosage (summary)
2 ml daily for upper body; 0.5 ml daily for scrotum, max 4 ml and 1 ml respectively.
Onset of Action / Duration
Onset: 24 hours, Duration: variable.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding; avoid contact.
Key Drug Interactions
- Increased anticoagulant effects
- Altered insulin sensitivity
- Increased ciclosporin toxicity
Contraindications
- Sensitivity to testosterone or excipients
- Carcinoma of breast or prostate
Common side effects
- Skin reactions
- Gynecomastia
- Mood changes
Counselling Points
- Wash hands after application
- Avoid contact with children and pregnant women
- Monitor for excessive androgen exposure
Serious warnings
- Risk of prostate cancer progression
- Potential for transfer to others
- Caution in cardiac, hepatic, renal disease
Important Disclaimer
The Testaforte 50 mg in 1 ml or 100 mg in 2 ml Cream. professional information leaflet below is the property of Pharmacorp and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
